S 1718
106th Congress
Senate
Taxation
AIDS (Disease)
Business income tax
Commerce
Communicable diseases
Congress
Congressional reporting requirements
Developing countries
Drug industry
Finance and Financial Sector
Health
Human immunodeficiency viruses
Income tax
International Affairs
International cooperation
Investment tax credit
Malaria
Medical research
Pharmaceutical research
Prescription pricing
Lifesaving Vaccine Technology Act of 1999
Introduced: October 12, 1999
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 12, 1999
Read twice and referred to the Committee on Finance.
Oct 12, 1999
Sponsor introductory remarks on measure. (CR S12422-12426)
Oct 12, 1999
Introduced in Senate
Plain-English summary
Lifesaving Vaccine Technology Act of 1999 - Amends the Internal Revenue Code to establish an income tax credit for 30 percent of the qualified expenses (excluding amounts funded by any grant, contract, or otherwise by another person or any governmental entity) for medical research related to developing vaccines against malaria, tuberculosis, or HIV.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1